Literature DB >> 19812757

International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities.

Shoumitro Deb1, Henry Kwok, Marco Bertelli, Luis Salvador-Carulla, Elspeth Bradley, Jennifer Torr, Jarret Barnhill.   

Abstract

Psychotropic medications are used regularly to manage problem behaviours among people with intellectual disabilities. This causes concern because often these medications are used out of their licensed indications in this context. The WPA Section on Psychiatry of Intellectual Disability has recently developed an evidence and consensus-based international guide for practitioners for the use of psychotropic medications for problem behaviours among adults with intellectual disabilities. This guide advises on assessment of behaviours, producing a formulation, initiation of treatment, assessment of out-come and adverse effects, follow-up arrangements, and possibility of discontinuation of treatment.

Entities:  

Keywords:  Intellectual disabilities; international guide; problem behaviours; psychotropic medications

Year:  2009        PMID: 19812757      PMCID: PMC2758582          DOI: 10.1002/j.2051-5545.2009.tb00248.x

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  24 in total

1.  Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.

Authors:  D J Clarke; S Kelley; K Thinn; J A Corbett
Journal:  J Ment Defic Res       Date:  1990-10

2.  Adults with intellectual disabilities: prevalence, incidence and remission of aggressive behaviour and related factors.

Authors:  S-A Cooper; E Smiley; A Jackson; J Finlayson; L Allan; D Mantry; J Morrison
Journal:  J Intellect Disabil Res       Date:  2008-10-29

3.  Side effects of atypical antipsychotics: a brief overview.

Authors:  Alp Uçok; Wolfgang Gaebel
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

4.  Meta-analytic study on treatment effectiveness for problem behaviors with individuals who have mental retardation.

Authors:  R Didden; P C Duker; H Korzilius
Journal:  Am J Ment Retard       Date:  1997-01

5.  Prevalence and cluster typology of maladaptive behaviors in a geographically defined population of adults with learning disabilities.

Authors:  S Smith; D Branford; R A Collacott; S A Cooper; C McGrother
Journal:  Br J Psychiatry       Date:  1996-08       Impact factor: 9.319

6.  Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities.

Authors:  D Branford
Journal:  J Intellect Disabil Res       Date:  1996-08

7.  Predicting the persistence of severe self-injurious behavior.

Authors:  E Emerson; C Kiernan; A Alborz; D Reeves; H Mason; R Swarbrick; L Mason; C Hatton
Journal:  Res Dev Disabil       Date:  2001 Jan-Feb

8.  Reducing antipsychotic medication in people with a learning disability.

Authors:  Z Ahmed; W Fraser; M P Kerr; C Kiernan; E Emerson; J Robertson; D Felce; D Allen; H Baxter; J Thomas
Journal:  Br J Psychiatry       Date:  2000-01       Impact factor: 9.319

9.  Challenging behaviours: prevalence and topographies.

Authors:  K Lowe; D Allen; E Jones; S Brophy; K Moore; W James
Journal:  J Intellect Disabil Res       Date:  2007-08

Review 10.  Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.

Authors:  Michael G Aman; Georges M Gharabawi
Journal:  J Clin Psychiatry       Date:  2004-09       Impact factor: 4.384

View more
  35 in total

1.  The implementation of the WPA Action Plan 2008-2011.

Authors: 
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

Review 2.  Polypharmacy in the treatment of subjects with intellectual disability.

Authors:  Frank Häβler; Johannes Thome; Olaf Reis
Journal:  J Neural Transm (Vienna)       Date:  2014-05-25       Impact factor: 3.575

3.  Primary care of adults with intellectual and developmental disabilities: 2018 Canadian consensus guidelines.

Authors:  William F Sullivan; Heidi Diepstra; John Heng; Shara Ally; Elspeth Bradley; Ian Casson; Brian Hennen; Maureen Kelly; Marika Korossy; Karen McNeil; Dara Abells; Khush Amaria; Kerry Boyd; Meg Gemmill; Elizabeth Grier; Natalie Kennie-Kaulbach; Mackenzie Ketchell; Jessica Ladouceur; Amanda Lepp; Yona Lunsky; Shirley McMillan; Ullanda Niel; Samantha Sacks; Sarah Shea; Katherine Stringer; Kyle Sue; Sandra Witherbee
Journal:  Can Fam Physician       Date:  2018-04       Impact factor: 3.275

4.  Primary care of adults with developmental disabilities: Canadian consensus guidelines.

Authors:  William F Sullivan; Joseph M Berg; Elspeth Bradley; Tom Cheetham; Richard Denton; John Heng; Brian Hennen; David Joyce; Maureen Kelly; Marika Korossy; Yona Lunsky; Shirley McMillan
Journal:  Can Fam Physician       Date:  2011-05       Impact factor: 3.275

Review 5.  Prescribing psychotropic drugs to adults with an intellectual disability.

Authors:  Julian N Trollor; Carmela Salomon; Catherine Franklin
Journal:  Aust Prescr       Date:  2016-08-01

Review 6.  Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research.

Authors:  Maire O'Dwyer; Philip McCallion; Mary McCarron; Martin Henman
Journal:  Ther Adv Drug Saf       Date:  2018-06-20

7.  Prevalence of psychotropic drug use in adults with intellectual disability: positive and negative findings from a large scale study.

Authors:  John A Tsiouris; Soh-Yule Kim; W Ted Brown; Jill Pettinger; Ira L Cohen
Journal:  J Autism Dev Disord       Date:  2013-03

8.  Successful management of difficult-to-treat aggression with low-dose propranolol in a patient with intellectual disability: a case report.

Authors:  Ravi Philip Rajkumar
Journal:  Prim Care Companion CNS Disord       Date:  2012-10-04

9.  [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].

Authors:  M Schützwohl; E Voss; M Stiawa; H-J Salize; B Puschner; A Koch
Journal:  Nervenarzt       Date:  2017-11       Impact factor: 1.214

10.  Mental illness, problem behaviour, needs and service use in adults with intellectual disability.

Authors:  Matthias Schützwohl; Andrea Koch; Nadine Koslowski; Bernd Puschner; Elke Voß; Hans Joachim Salize; Andrea Pfennig; Anke Vogel
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-03-07       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.